Form 4: Fulgent Genetics CFO Paul Kim Reports Stock Withholding

CFO Paul Kim disposed of 2,087 shares of Fulgent Genetics common stock to satisfy tax obligations related to RSU vesting.

Summary

• Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reported the disposition of 2,087 shares of common stock.
• The transaction occurred on June 1, 2026, at a price of $18.09 per share.
• The shares were withheld by the company to cover tax withholding obligations resulting from the vesting of restricted stock units (RSUs).
• Following this transaction, Paul Kim maintains beneficial ownership of 362,545 shares of Fulgent Genetics common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event, as the share reduction is purely for tax compliance purposes.

Positives

• The transaction was a routine administrative action to satisfy tax obligations rather than a discretionary market sale.

Negatives

• The transaction represents a reduction in the reporting person's direct shareholding.

Risks

• None identified; this is a standard tax-related withholding event.

Future Outlook

No forward-looking guidance or strategic outlook provided in this filing.

Industry Context

StockSavvy.ai notes that tax-related share withholding is a standard corporate governance practice for executives receiving equity compensation and does not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices in the biotechnology and diagnostics sector.
• The use of net-settlement for tax obligations is a common industry practice to avoid open-market sales by insiders.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax-related withholding.

Key Dates

Keywords

Fulgent Genetics, FLGT, Insider Trading, Form 4, CFO, Tax Withholding